These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1419293)

  • 1. Unexpected prolonged myelosuppression after mitomycin, mitoxantrone and methotrexate.
    Muhonen TT; Wiklund TA; Blomqvist CP; Pyrhönen SO
    Eur J Cancer; 1992; 28A(12):1974-6. PubMed ID: 1419293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelosuppression after methotrexate, mitoxantrone, and mitomycin C.
    Jodrell DI; Iveson TJ; Smith IE
    Lancet; 1987 May; 1(8543):1211. PubMed ID: 2883528
    [No Abstract]   [Full Text] [Related]  

  • 3. A randomised comparative trial of mitozantrone/methotrexate/mitomycin C (MMM) and cyclophosphamide/methotrexate/5 FU (CMF) in the treatment of advanced breast cancer.
    Jodrell DI; Smith IE; Mansi JL; Pearson MC; Walsh G; Ashley S; Sinnett HD; McKinna JA
    Br J Cancer; 1991 May; 63(5):794-8. PubMed ID: 2039705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelosuppression after methotrexate, mitozantrone, and mitomycin C for treatment of advanced breast cancer.
    Marks A; Goodman A; Dougherty S; Ashford R
    Lancet; 1987 Apr; 1(8538):915. PubMed ID: 2882308
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute myeloid leukemia following 3M (mitoxantrone, mitomycin and methotrexate) chemotherapy for advanced breast cancer.
    Melillo LM; Sajeva MR; Musto P; Perla G; Cascavilla N; Minervini MM; D'Arena G; Carotenuto M
    Leukemia; 1997 Dec; 11(12):2211-3. PubMed ID: 9447844
    [No Abstract]   [Full Text] [Related]  

  • 6. Myelotoxicity of methotrexate, mitozantrone, and mitomycin C.
    Morton AR; Anderson H; Howell A
    Lancet; 1987 Jun; 1(8548):1494. PubMed ID: 2885486
    [No Abstract]   [Full Text] [Related]  

  • 7. Mitoxantrone, mitomycin-C, methotrexate combination chemotherapy with radiotherapy and/or surgery in stage III (T4B, NO-2, M0) breast cancer.
    Raina V; Sharma A; Deo SV; Shukla NK; Mohanty BK; Goel A; Rath GK
    J Assoc Physicians India; 1998 Nov; 46(11):926-9. PubMed ID: 11229215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of advanced breast cancer with mitomycin C combined with vinblastine or vindesine.
    Garewal HS; Brooks RJ; Jones SE; Miller TP
    J Clin Oncol; 1983 Dec; 1(12):772-5. PubMed ID: 6422004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelosuppression after methotrexate, mitozantrone, and mitomycin C combination chemotherapy.
    Powles TI; Ashley S
    Lancet; 1987 Oct; 2(8563):853. PubMed ID: 2889049
    [No Abstract]   [Full Text] [Related]  

  • 10. The efficacy of 5-fluorouracil, mitomycin C, and methyl CCNU in advanced colorectal cancer.
    Vaughn CB; Chapman J; Garland M; Pederson B; Demitrish MM; Chinn B; Ward D; Enochs K; Groshko G; Rocchio R
    Am J Clin Oncol; 1986 Jun; 9(3):196-9. PubMed ID: 3088974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of metastatic colorectal carcinoma with 5-FU, mitomycin, vincristine, and methotrexate.
    Beck TM; Curtis PW; Woodard DA; Hart NE; Smith CE
    Cancer Treat Rep; 1984 Apr; 68(4):647-50. PubMed ID: 6424937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancer.
    Powles TJ; Jones AL; Judson IR; Hardy JR; Ashley SE
    Br J Cancer; 1991 Aug; 64(2):406-10. PubMed ID: 1892775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, controlled, multicenter phase III trial of standard-dose fluorouracil-epirubicin-cyclophosphamide (FEC), compared with time-intensive FEC (FEC-G) and mitoxantrone-methotrexate-mitomycin C (MMM-G) in metastatic breast carcinoma.
    Capotorto AM; Pavesi L; Pedrazzoli P; Da Prada GA; Zamagni C; Massidda B; Farris A; Martoni A; Lelli G; Robustelli della Cuna G
    J Chemother; 2003 Apr; 15(2):184-91. PubMed ID: 12797397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitomycin C and mitoxantrone chemotherapy for advanced breast cancer: efficacy with minimal gastrointestinal toxicity and alopecia.
    Panasci L; Shenouda G; Begin L; Pollak M; Reinke A; Margolese R
    Cancer Chemother Pharmacol; 1990; 26(6):457-60. PubMed ID: 2121379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adriamycin, dibromodulcitol, and mitomycin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone.
    Pinnamaneni K; Yap HY; Buzdar AU; Distefano A; Blumenschein GR
    Cancer; 1984 May; 53(9):1841-4. PubMed ID: 6546706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematologic toxicity of cisplatin and mitomycin in combination for squamous cell carcinoma of esophagus.
    Stoll DB; Lavin PT; Engstrom PF
    Am J Clin Oncol; 1985 Jun; 8(3):231-4. PubMed ID: 4050741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of vincristine, mitomycin-C and mitoxantrone in advanced breast cancer: a preliminary report of response and toxicity.
    Perren TJ; Blackledge G; Mould JJ; Chetiyawardana AD; Morrison M; Hancock A
    Invest New Drugs; 1985; 3(2):173-7. PubMed ID: 3926713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary leukaemia after MMM combined modality therapy for breast carcinoma.
    Philpott NJ; Bevan DH; Gordon-Smith EC
    Lancet; 1993 May; 341(8855):1289. PubMed ID: 8098437
    [No Abstract]   [Full Text] [Related]  

  • 19. Mitomycin C, melphalan and methotrexate combination chemotherapy for palliation of disseminated breast cancer.
    Perez DJ; Powles TJ; Gazet JC; Ford HT; Coombes RC
    Cancer Chemother Pharmacol; 1984; 13(1):36-8. PubMed ID: 6203662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of 5-fluorouracil and high-dose folinic acid in combination with cyclophosphamide and mitoxantrone for advanced breast cancer.
    Aitini E; Cavazzini G; Cantore M; Rabbi C; Rivera A; Togliani B; Di Marco A; Smerieri F
    Eur J Cancer; 1992; 28A(12):1968-70. PubMed ID: 1419291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.